FinnCap reissued their corporate rating on shares of ANGLE plc (LON:AGL) in a report issued on Monday morning, Marketbeat.com reports. The brokerage currently has a GBX 100 ($1.31) price target on the stock, down from their previous price target of GBX 108 ($1.42).
Separately, Beaufort Securities reaffirmed a speculative buy rating on shares of ANGLE plc in a research note on Wednesday, July 5th.
Shares of ANGLE plc (LON AGL) opened at 43.00 on Monday. The stock’s market cap is GBX 31.54 million. The firm has a 50 day moving average of GBX 36.80 and a 200 day moving average of GBX 48.47. ANGLE plc has a one year low of GBX 32.27 and a one year high of GBX 80.00.
ANGLE plc Company Profile
ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.
What are top analysts saying about ANGLE plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ANGLE plc and related companies.